JAN (NYSE:JAN) Sets New 12-Month High - Still a Buy?

Key Points

• JAN shares hit a new 52‑week high of $26.74 and were trading around $26.43, reflecting renewed investor attention.
• Multiple firms recently initiated coverage with bullish ratings (Buy/Overweight/Outperform), leaving an average price target of about $27.27.
• Insider buying is notable (CEO bought 100,000 shares, a director bought 13,500; 187,000 shares purchased in the last 90 days), but the stock remains unprofitable (trailing P/E ≈ -62.29) and high‑beta (~2.16), increasing volatility and risk.

JAN (NYSE:JAN - Get Free Report) shares reached a new 52-week high during trading on Tuesday . The stock traded as high as $26.74 and last traded at $26.4250, with a volume of 13291 shares trading hands. The stock had previously closed at $26.32.

Key Stories Impacting JAN

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Increased coverage/visibility — a comparison piece that pits JAN against peer Fermi may draw fresh investor attention and fresh flows into the name as readers re‑evaluate relative value; that attention can be constructive if it leads to renewed analyst checks or fund buys. Comparing JAN NYSE: JAN and Fermi NASDAQ: FRMI
• Neutral Sentiment: Published comparison article — the piece on JAN vs. FRMI provides context (valuation, business model, risk profile). It’s informational and may prompt short-term positioning changes, but it does not appear to contain company-specific catalysts (earnings, guidance, M&A) that would clearly move fundamentals. Comparing JAN NYSE: JAN and Fermi NASDAQ: FRMI
• Negative Sentiment: Low intraday liquidity — today’s volume (~172k) is far below JAN’s average volume (~1.12M), which can exaggerate price moves and discourage larger traders. This likely contributed to the modest downward move.
• Negative Sentiment: Unprofitable/valuation signal — JAN shows a negative P/E, indicating it’s not profitable on trailing earnings; that raises sensitivity to any weak operational news and can cap investor appetite until profitability or clearer growth prospects emerge.
• Negative Sentiment: Higher volatility profile — the stock’s beta (~2.16) suggests it will swing more than the market, so in a risk‑off session investors may trim positions faster than for lower‑beta names.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Barclays assumed coverage on shares of JAN in a research report on Tuesday, April 14th. They issued an "overweight" rating and a $26.00 price objective on the stock. Royal Bank Of Canada started coverage on shares of JAN in a research note on Tuesday, April 14th. They issued an "outperform" rating and a $27.00 price target on the stock. Bank of America started coverage on JAN in a research report on Tuesday, April 14th. They set a "buy" rating and a $29.00 price target on the stock. Scotiabank started coverage on JAN in a research report on Tuesday, April 14th. They set a "sector outperform" rating and a $28.00 price target on the stock. Finally, Cantor Fitzgerald started coverage on JAN in a research report on Monday, April 13th. They set an "overweight" rating and a $27.00 price target on the stock. Ten equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, JAN has an average rating of "Moderate Buy" and an average price target of $27.27.

JAN Stock Performance

The firm has a market cap of $6.75 billion, a PE ratio of -62.29 and a beta of 2.16.

Insider Buying and Selling

In other news, Director Katherine M. Sandstrom bought 13,500 shares of the company's stock in a transaction dated Monday, March 23rd. The shares were bought at an average cost of $20.00 per share, with a total value of $270,000.00. Following the acquisition, the director owned 21,000 shares in the company, valued at $420,000. This trade represents a 180.00% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Scott M. Brinker bought 100,000 shares of the company's stock in a transaction dated Monday, March 23rd. The stock was purchased at an average cost of $20.00 per share, for a total transaction of $2,000,000.00. Following the completion of the acquisition, the chief executive officer owned 100,000 shares in the company, valued at $2,000,000. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 187,000 shares of company stock worth $3,740,000 in the last 90 days. 3.00% of the stock is owned by corporate insiders.

About JAN

Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.